355 related articles for article (PubMed ID: 25402380)
1. The influence of combined oral contraceptives containing drospirenone on hypothalamic-pituitary-adrenocortical axis activity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.
Macut D; Božić Antić I; Nestorov J; Topalović V; Bjekić Macut J; Panidis D; Kastratović Kotlica B; Papadakis E; Matić G; Vojnović Milutinović D
Hormones (Athens); 2015; 14(1):109-17. PubMed ID: 25402380
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic-pituitary-adrenocortical axis hypersensitivity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.
Milutinović DV; Macut D; Božić I; Nestorov J; Damjanović S; Matić G
Exp Clin Endocrinol Diabetes; 2011 Nov; 119(10):636-43. PubMed ID: 22068557
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
De Leo V; Di Sabatino A; Musacchio MC; Morgante G; Scolaro V; Cianci A; Petraglia F
Contraception; 2010 Sep; 82(3):276-80. PubMed ID: 20705157
[TBL] [Abstract][Full Text] [Related]
4. Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination.
Aydin K; Cinar N; Aksoy DY; Bozdag G; Yildiz BO
Contraception; 2013 Mar; 87(3):358-62. PubMed ID: 22898361
[TBL] [Abstract][Full Text] [Related]
5. Effect of chlormadinone acetate versus drospirenone-containing oral contraceptives on the endocrinal features of women with polycystic ovary syndrome: Systematic review and meta-analysis of randomized clinical trials.
Menshawy A; Ismail A; Abdel-Maboud M; El-Din AA; Elgebaly A; Gadelkarim M; Bahbah EI; Abdelghany MF; Samy A; Abbas AM
J Gynecol Obstet Hum Reprod; 2019 Nov; 48(9):763-770. PubMed ID: 30940512
[TBL] [Abstract][Full Text] [Related]
6. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.
Cinar N; Cetinozman F; Aksoy DY; Elcin G; Yildiz BO
J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476
[TBL] [Abstract][Full Text] [Related]
7. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
8. Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.
Coelingh Bennink HJT; Zimmerman Y; Laan E; Termeer HMM; Appels N; Albert A; Fauser BCJM; Thijssen JHH; van Lunsen RHW
Contraception; 2017 Nov; 96(5):322-329. PubMed ID: 27393080
[TBL] [Abstract][Full Text] [Related]
9. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.
Zimmerman Y; Foidart JM; Pintiaux A; Minon JM; Fauser BC; Cobey K; Coelingh Bennink HJ
Contraception; 2015 Feb; 91(2):127-33. PubMed ID: 25604900
[TBL] [Abstract][Full Text] [Related]
10. Age, body mass index, and serum level of DHEA-S can predict glucocorticoid receptor function in women with polycystic ovary syndrome.
Macut D; Vojnović Milutinović D; Božić I; Matić G; Brkljačić J; Panidis D; Petakov M; Spanos N; Bjekić J; Stanojlović O; Petrović Milinković A; Radojičić Z; Damjanović S
Endocrine; 2010 Feb; 37(1):129-34. PubMed ID: 20963561
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
Kriplani A; Periyasamy AJ; Agarwal N; Kulshrestha V; Kumar A; Ammini AC
Contraception; 2010 Aug; 82(2):139-46. PubMed ID: 20654754
[TBL] [Abstract][Full Text] [Related]
12. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome.
Morgante G; Cappelli V; Troìa L; De Leo V
Eur J Contracept Reprod Health Care; 2020 Jun; 25(3):176-181. PubMed ID: 32191532
[No Abstract] [Full Text] [Related]
14. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
Lanzone A; Guido M; Ciampelli M; Fulghesu AM; Pavone V; Proto C; Caruso A; Mancuso S
Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
[TBL] [Abstract][Full Text] [Related]
15. Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.
Mawet M; Maillard C; Klipping C; Zimmerman Y; Foidart JM; Coelingh Bennink HJ
Eur J Contracept Reprod Health Care; 2015; 20(6):463-75. PubMed ID: 26212489
[TBL] [Abstract][Full Text] [Related]
16. Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone).
Podfigurna A; Meczekalski B; Petraglia F; Luisi S
J Endocrinol Invest; 2020 Apr; 43(4):483-492. PubMed ID: 31654312
[TBL] [Abstract][Full Text] [Related]
17. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.
Buyalos RP; Geffner ME; Azziz R; Judd HL
Hum Reprod; 1997 Jun; 12(6):1138-41. PubMed ID: 9221990
[TBL] [Abstract][Full Text] [Related]
18. Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women.
Giribela CR; Consolim-Colombo FM; Nisenbaum MG; Moraes TL; Giribela AH; Baracat EC; Melo NR
Gynecol Endocrinol; 2015; 31(11):912-5. PubMed ID: 26172927
[TBL] [Abstract][Full Text] [Related]
19. The effect of drospirenone (3 mg) with ethinyl estradiol (30 mcg) containing pills on ovarian blood flows in women with polycystic ovary syndrome: a case controlled study.
Okyay E; Gode F; Acet F; Bodur T; Cagliyan E; Sahan C; Posaci C; Gulekli B
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():93-9. PubMed ID: 25063905
[TBL] [Abstract][Full Text] [Related]
20. Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men.
Mattsson C; Reynolds RM; Simonyte K; Olsson T; Walker BR
J Clin Endocrinol Metab; 2009 Apr; 94(4):1347-52. PubMed ID: 19141586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
